These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3225762)

  • 1. Impact of dosage regimens on the efficacy of piperacillin against Pseudomonas aeruginosa in neutropenic mice.
    Zhi JG; Nightingale CH; Quintiliani R
    J Pharm Sci; 1988 Nov; 77(11):991-2. PubMed ID: 3225762
    [No Abstract]   [Full Text] [Related]  

  • 2. Pseudomonas peritonitis in neutropenic rats treated with amikacin, ceftazidime and ticarcillin, alone and in combination.
    Shyu WC; Nightingale CH; Quintiliani R
    J Antimicrob Chemother; 1987 Jun; 19(6):807-14. PubMed ID: 3112102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of azlocillin and ticarcillin in febrile neutropenic children with cancer: a comparative study.
    Kosmidis H; Varvoutsi M; Kafetzis D; Koupari G; Bouhoutsou D; Papadatos C
    Chemioterapia; 1987 Jun; 6(2 Suppl):396-8. PubMed ID: 3334581
    [No Abstract]   [Full Text] [Related]  

  • 4. Bacteremia in neutropenic patients at a major teaching hospital--1981 to 1987.
    Rawlinson W; Sorrell T; Munro R
    Aust N Z J Med; 1988 Oct; 18(6):815-7. PubMed ID: 3242473
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice.
    Gerber AU; Craig WA; Brugger HP; Feller C; Vastola AP; Brandel J
    J Infect Dis; 1983 May; 147(5):910-7. PubMed ID: 6842025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
    Fu KP; Hetzel N; Gregory FJ; Hung PP
    J Antimicrob Chemother; 1987 Oct; 20(4):541-6. PubMed ID: 3680089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single versus combination antibiotic therapy for pneumonia due to Pseudomonas aeruginosa in neutropenic guinea pigs.
    Rusnak MG; Drake TA; Hackbarth CJ; Sande MA
    J Infect Dis; 1984 Jun; 149(6):980-5. PubMed ID: 6429255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE; Small GJ
    J Infect Dis; 1987 May; 155(5):973-8. PubMed ID: 3104484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in resistance of Pseudomonas aeruginosa to beta-lactams in a general intensive care unit over a three-year period. Role of piperacillin].
    Bercault N; Martin P; Demasure M; Poisson D; Gueveler C
    Pathol Biol (Paris); 1991 Feb; 39(2):105-9. PubMed ID: 1901983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE
    Antibiot Chemother (1971); 1987; 39():51-9. PubMed ID: 3118791
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergy between ticarcillin/clavulanic acid and aminoglycosides against Pseudomonas aeruginosa infections in neutropenic mice.
    Smith GM; Beale AS; Slocombe B
    J Chemother; 1989 Jul; 1(4 Suppl):82-3. PubMed ID: 16312314
    [No Abstract]   [Full Text] [Related]  

  • 13. Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa.
    Zhi JG; Nightingale CH; Quintiliani R
    J Pharmacokinet Biopharm; 1988 Aug; 16(4):355-75. PubMed ID: 3193364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime.
    Daenen S; de Vries-Hospers H
    Lancet; 1988 Apr; 1(8591):937. PubMed ID: 2895853
    [No Abstract]   [Full Text] [Related]  

  • 15. Ceftazidime alone for treating Pseudomonas aeruginosa septicaemia in neutropenic patients.
    Verhagen C; de Pauw BE; Donnelly JP; Williams KJ; de Witte T; Janssen TH
    J Infect; 1986 Sep; 13(2):125-31. PubMed ID: 3093589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic activity of apalcillin and gentamicin in a combination therapy in experimental Pseudomonas bacteraemia of neutropenic mice.
    Fu KP; Hetzel N; Hung PP; Gregory FJ
    J Antimicrob Chemother; 1986 Apr; 17(4):499-503. PubMed ID: 3710958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two neutropenic patients with multiple resistant Pseudomonas aeruginosa septicaemia treated with ciprofloxacin.
    Bendig JW; Kyle PW; Giangrande PL; Samson DM; Azadian BS
    J R Soc Med; 1987 May; 80(5):316-7. PubMed ID: 3112380
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapy of neutropenic rats infected with Pseudomonas aeruginosa.
    Lumish RM; Norden CW
    J Infect Dis; 1976 May; 133(5):538-47. PubMed ID: 816976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of infectious outbreaks in neutropenic patients with a piperacillin and amikacin combination].
    Calvo F; de Castro H; Brice P
    Presse Med; 1986 Dec; 15(46):2353-7. PubMed ID: 2949286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.